Since in vivo studies indicate that older erythro cytes hemolyze preferentially in drug-induced hemolysis, differential centrifugation was used to separate young and old normal and G-6-PD deficient erythrocytes. Older cells were identified by their lower level of G-6-PD activity; in corporation of 59Fe into erythrocytes confirmed this division of cells by age. Mechanical fragility (MF) of old cells was greater than that of young cells. Effects of 8-amino-5,6-quino linediol (AQD) (a possible primaquine metabolite) and of 2-hydroxyphenetidine (HP) (a phenacetin metabolite) on hemolysis, MF and reduced glutathione (GSH) and methemoglobin content were examined in vitro. AQD (2.5 × 10–4 m) did not produce hemolysis but selectively increased MF of old G-6-PD deficient cells. HP (5 × 10–4 m) produced considerable hemolysis of both normal and G-6-PD deficient cells with a selective effect in old G-6-PD deficient cells. HP also selectively increased the MF of old G-6-PD deficient cells. Incubation with AQDor HP depleted GSH content more in old than in young G-6-PD deficient cells. This depletion of GSH was followed by increased MF of old G-6-PD deficient cells. Hemolysis of normal cells occurred without GSH depletion but was accompanied by GSH depletion in G-6-PD deficient cells. Smaller differences in methemoglobin formation occurred but were not well correlated with hemolysis or increased MF. Although not applicable as a routine diagnostic test in the clinical laboratory, increased MF in vitro of old G-6-PD deficient erythrocytes is suggested as a useful research tool in assessing the potential of drugs or drug metabolites to cause hemolysis in vivo, particularly in combination with parallel studies of glutathione depletion.

Keywords:
Pharmacogenetics, G-6-PD deficiency, Erythrocyte age, Mechanical fragility, Hemolysis, Glutathione, Methemoglobin
This content is only available via PDF.
© 1971 S. Karger AG, Basel
1971
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.